Cargando…
Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer
BACKGROUND: Chemotherapy remains a standard treatment option for breast cancer despite its toxic effects to normal tissues. However, the long-lasting effects of chemotherapy on non-malignant cells may influence tumor cell behavior and response to treatment. Here, we have analyzed the effects of doxo...
Autores principales: | Plava, Jana, Burikova, Monika, Cihova, Marina, Trnkova, Lenka, Smolkova, Bozena, Babal, Pavel, Krivosikova, Lucia, Janega, Pavol, Rojikova, Lucia, Drahosova, Slavka, Bohac, Martin, Danisovic, Lubos, Kucerova, Lucia, Miklikova, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477536/ https://www.ncbi.nlm.nih.gov/pubmed/34579743 http://dx.doi.org/10.1186/s13046-021-02087-2 |
Ejemplares similares
-
Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy
por: Plava, Jana, et al.
Publicado: (2020) -
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
por: Plava, Jana, et al.
Publicado: (2019) -
The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
por: Miklikova, Svetlana, et al.
Publicado: (2021) -
Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients
por: Cierna, Zuzana, et al.
Publicado: (2021) -
Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer
por: Miklikova, Svetlana, et al.
Publicado: (2020)